Old Web
English
Sign In
Acemap
>
Paper
>
Incidence of the BCR-ABL Kinase Domain Mutations in Imatinib Treated CML Patients: Russian Experience
Incidence of the BCR-ABL Kinase Domain Mutations in Imatinib Treated CML Patients: Russian Experience
2011
A. V. Misyurin
Elena N Misyurina
Alexey Krutov
Elena Aksenova
Irina Soldatova
Laura Kesaeva
Turkina Ag
Ekaterina Chelysheva
Valeri G. Savchenko
Parovichnikova En
Keywords:
ABL
Immunology
Protein kinase domain
breakpoint cluster region
Imatinib
Medicine
Mutation
Cancer research
Dasatinib
Nilotinib
imatinib mesylate
Bcr-Abl Tyrosine Kinase
bcr abl kinase
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]